Advanced Sterilization Products (ASP) is a leader in infection prevention, dedicated to creating the products, solutions and processes needed by practitioners to protect patients during their most critical moments. ASP solutions include capital, consumables and software for use in Low-Temperature Terminal Sterilization and High-Level Disinfection of reusable surgical instruments. All contents © Copyright Johnson & Johnson Services, Inc.1997-2020. Capitalized product names are trademarks of Advanced Sterilization Products, Inc. Please see our Privacy Policy. NEW BRUNSWICK, N.J., April 1, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its Advanced Sterilization Products (ASP) business, a division of Ethicon, Inc. *, to Fortive Corporation (NYSE: FTV) for an aggregate value of approximately $2.8 billion, consisting of $2.7 billion of cash proceeds from Fortive Corporation and … About Johnson & Johnson This link will take you to a website to which this Privacy Policy does not apply. All Rights Reserved. Ethicon, part of Johnson & Johnson Medical Devices Companies, has made significant contributions to surgery for more than 100 years from creating the first sutures, to revolutionizing surgery with minimally invasive procedures. ASP supports healthcare facilities in the fight to protect patients against hospital-acquired infections, which are a leading cause of morbidity and mortality. Contact Us with any questions or search this site for more information.EEO Is the Law | EEO Is the Law GINA Supplement. All contents © Copyright Johnson & Johnson Services, Inc.1997-2018. This site is published by ASP International GmbH which is solely responsible for its contents. EVERETT, Wash.-- (BUSINESS WIRE)--Fortive Corporation ("Fortive") (NYSE: FTV) announced today that it has completed the acquisition of the Advanced Sterilization Products (“ASP”… Through Ethicon's surgical technologies and solutions including sutures, staplers, energy devices, trocars and adjunctive hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. *Advanced Sterilization Products, a division of Ethicon, Inc., a New Jersey corporation. Johnson & Johnson Completes Divestiture of Advanced Sterilization Products (ASP) to Fortive Corporation, This site uses cookies as described in our. For more information, visit www.ethicon.com. All Rights Reserved. ASP supports healthcare facilities in the fight to protect patients against hospital-acquired infections, which are a leading cause of morbidity and mortality. View original content to download multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-completes-divestiture-of-advanced-sterilization-products-asp-to-fortive-corporation-300822090.html, Press Contact: Natalia Salomao, (732) 220-4963, (732) 325-8306 (M); Investor Relations Contact: Matthew Stuckley, (732) 524-2617, Pharmaceutical Companies of Johnson & Johnson, Advancing New Healthcare Solutions Through Collaboration, Reimagining the Way Healthcare Is Delivered, Learn About the Company's Rich Heritage at Our Digital Museum. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. ASP is a global leader in innovative infection prevention solutions with 2018 net revenue of approximately $800 million. Through Ethicon's surgical technologies and solutions including sutures, staplers, energy devices, trocars and adjunctive hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. ASP is a leader in infection prevention, dedicated to creating the products, solutions, and processes needed by practitioners to protect patients during their most critical moments. NEW BRUNSWICK, N.J., April 1, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its Advanced Sterilization Products (ASP) business, a division of Ethicon, Inc.*, to Fortive Corporation (NYSE: FTV) for an aggregate value of approximately $2.8 billion, consisting of $2.7 billion of cash proceeds from Fortive Corporation and $0.1 billion of retained net receivables.